Market Cap 4.94B P/E - EPS this Y -48.60% Ern Qtrly Grth -
Income -155.47M Forward P/E -22.03 EPS next Y 3.00% 50D Avg Chg -11.00%
Sales 115.91M PEG -5.87 EPS past 5Y - 200D Avg Chg -30.00%
Dividend N/A Price/Book 6.79 EPS next 5Y 4.30% 52W High Chg -51.00%
Recommedations 1.70 Quick Ratio 6.90 Shares Outstanding 140.31M 52W Low Chg 16.00%
Insider Own 5.20% ROA -10.24% Shares Float 89.87M Beta -
Inst Own 81.79% ROE -24.34% Shares Shorted/Prior 4.78M/4.30M Price 35.24
Gross Margin -32.07% Profit Margin -134.12% Avg. Volume 1,182,451 Target Price 61.20
Oper. Margin -137.58% Earnings Aug 9 Volume 932,707 Change 2.41%
Adaptive Biotechnologies Corpor News
08:16 AM QIAGEN (QGEN) Gains from FDA's EUA for Antibody Total Test
07:07 AM Bayer (BAYRY) Inks Deal to Develop Therapies for Eye Diseases
05/17/21 Dr. Reddy's (RDY) Q4 Earnings Decline Y/Y, Sales Increase
05/11/21 Perrigo (PRGO) Q1 Earnings Miss Estimates, Revenues In Line
05/11/21 Axsome's (AXSM) Q1 Earnings Top, AXS-05 Launch in Focus
05/11/21 Catalyst (CPRX) Q1 Earnings Beat Estimates, Revenues Miss
05/06/21 Adaptive Biotechnologies Corporation (ADPT) Q1 2021 Earnings Call Transcript
05/05/21 Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Tops Revenue Estimates
05/05/21 Adaptive Biotechnologies Reports First Quarter 2021 Financial Results
04/28/21 Earnings Preview: Adaptive Biotechnologies (ADPT) Q1 Earnings Expected to Decline
04/27/21 Adaptive Biotechnologies to Present at the BofA Securities 2021 Virtual Healthcare Conference
04/12/21 Adaptive Biotechnologies to Report First Quarter Financial Results on May 5, 2021
04/12/21 What Type Of Shareholders Make Up Adaptive Biotechnologies Corporation's (NASDAQ:ADPT) Share Registry?
03/17/21 Adaptive Biotechnologies Strengthens Expertise and Diversity of Board of Directors with Appointments of Leslie Trigg and Katey Owen
03/08/21 FDA Authorizes New Category of Covid-19 Test
03/08/21 Looking Into Adaptive Biotechnologies's Return On Capital Employed
03/08/21 FDA authorizes Adaptive's T-cell test for people who have already had COVID-19
03/08/21 Adaptive Biotechnologies Secures FDA EUA For COVID-19 T-Cell Response Test
03/08/21 Adaptive Biotech COVID Blood Test Cleared for Emergency Use

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ research service and kit that is used to answer research questions, as well as to discover new prognostic and diagnostic signals. It also provides clonoSEQ diagnostic tests, which include immunosequencing services for use in the detection and monitoring of minimal residual disease in patients with select blood cancers. In addition, the company offers a pipeline of clinical products and services that are used for the diagnosing, monitoring, and treatment of diseases, such as cancer, autoimmune conditions, and infectious diseases. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test; and Amgen to develop a therapeutic to prevent or treat COVID-19. It serves the life sciences research, clinical diagnostics, and drug discovery customers. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was founded in 2009 and is headquartered in Seattle, Washington.

ADPT Chatroom

User Image healthcareguru Posted - 6 hours ago

Short Press the overvalued junk: $SEER $ASXC $MASS $SDGR $ADPT πŸΊπŸ‘Ž

User Image cctranscripts Posted - 22 hours ago

Adeptus Health Inc.'s Chief People Officer just cashed-in 2,000 options https://www.conferencecalltranscripts.com/summary/?id=9422485 $ADPT

User Image Newsfilter Posted - 23 hours ago

$ADPT $52,000.00 of shares sold by Lo Francis (Chief People Officer), reported in a new form 4 filed with the SEC https://newsfilter.io/a/9edd4cf71e56b2277f4f37e1fdca1709

User Image risenhoover Posted - 23 hours ago

Insider Francis Lo reports selling 2,000 shares of $ADPT for a total cost of $67,600.00 https://fintel.io/n/us/adpt/lo-francis?utm_source=stocktwits.com&utm_medium=Referral&utm_campaign=insider

User Image Quantisnow Posted - 23 hours ago

$ADPT πŸ“œ SEC Form 4: LO FRANCIS exercised 2,000 units of Common Stock at a strike of $7.80 and sold $67,600 worth of Common Stock (2,000 units at $33.80) https://quantisnow.com/insight/753107?s=s #healthcare

User Image fla Posted - 23 hours ago

$ADPT [15s. delayed] filed SEC form 4: Chief People Officer LO FRANCIS: Disposed 2,000 of Common Stock at price $33.8 and Converted secur https://s.flashalert.me/q6gFc

User Image TradeWithAlerts Posted - 1 day ago

New Print for $ADPT - Amount: $3,949,962.41 - to learn more, take a training https://tradewithalerts.com/training OR if you know trading around prints sign up.

User Image CZARBETS Posted - 1 day ago

$ADPT institutional ownership down 1.5% from 82.3% to 80.8%

User Image CZARBETS Posted - 1 day ago

$ADPT short float down 0.01% from 3.72% to 3.71%

User Image QuiverQuant Posted - 3 days ago

ALERT: $ADPT Received Approval for a New Patent on: 2021-05-11 SOURCE: https://www.quiverquant.com/patentsearch/ticker/ADPT?searchticker=ADPT

User Image Insider_Analysis Posted - 3 days ago

$ADPT Chad M Cohen sold 20,000 shares [High Conviction] www.insider-analysis.com/search_transactions.php?ticker=TABLE_ADPT

User Image basscat12 Posted - 4 days ago

ARK Watcher; Biggest Increase in Shares Held: $ZY $RXRX $ADPT $PATH $TSP

User Image risenhoover Posted - 4 days ago

Insider Chad M Cohen reports selling 20,000 shares of $ADPT for a total cost of $641,641.93 https://fintel.io/n/us/adpt/cohen-chad-m?utm_source=stocktwits.com&utm_medium=Referral&utm_campaign=insider

User Image FilingsVille Posted - 4 days ago

$ADPT: New SEC filing on Chief Financial Officer, CHAD M COHEN: https://www.sec.gov/Archives/edgar/data/1478320/000120919121032438/xslF345X03/doc4.xml

User Image Gokugod Posted - 4 days ago

$ADPT RECENT Twits Trends Today's Change 7 % + https://t8sk.com/ADPT

User Image MarketBeatInsiderTrades Posted - 5 days ago

Adaptive Biotechnologies CFO Chad Cohen Sells $326,300.00 in $ADPT https://www.marketbeat.com/i/445550

User Image cctranscripts Posted - 5 days ago

Adeptus Health Inc.'s Chief Financial Officer just cashed-in 20,000 options https://www.conferencecalltranscripts.com/summary/?id=9403588 $ADPT

User Image fla Posted - 5 days ago

$ADPT [15s. delayed] filed SEC form 4: Chief Financial Officer Cohen Chad M: Disposed 20,000 of Common Stock at average price $32.08 and https://s.flashalert.me/opGOw4

User Image Quantisnow Posted - 5 days ago

$ADPT πŸ“œ SEC Form 4: Cohen Chad M sold $641,642 worth of Common Stock (20,000 units at $32.08) and exercised 20,000 units of Common Stock at a strike of $6.55 https://quantisnow.com/insight/741957?s=s #healthcare

User Image Newsfilter Posted - 5 days ago

$ADPT $510,641.93 of shares sold by Cohen Chad M (Chief Financial Officer), reported in a new form 4 filed with the SEC https://newsfilter.io/a/f5805dbf8a34974bb2806ba54bdbfdc3

User Image TradeWithAlerts Posted - 5 days ago

Nice Print for $ADPT - Amount: $3,399,425.32 - to learn more, SIGNUP https://tradewithalerts.com/signup or get a training https://tradewithalerts.com/training!

User Image TradeWithAlerts Posted - 5 days ago

Nice Print for $ADPT - Amount: $4,600,022.88 - to learn more, SIGNUP https://tradewithalerts.com/signup or get a training https://tradewithalerts.com/training!

User Image MarketBeat Posted - 5 days ago

Adaptive Biotechnologies's PT cut by Morgan Stanley to $55.00. equal weight rating. https://www.marketbeat.com/r/1597438 $ADPT

User Image SonGoku Posted - 5 days ago

Ark loading $CDXS $BLI $BFLY $ADPT

User Image CZARBETS Posted - 6 days ago

$ADPT short float up 0.32% from 3.4% to 3.72%

User Image EarningsInsider Posted - 6 days ago

$ADPT updates FY 2021 guidance to - EPS and revenue guidance to $145 million-$155 million. https://www.marketbeat.com/g/60136

User Image SonGoku Posted - 6 days ago

Ark loading $IONS $CMIIU $ADPT $CDNA

User Image chris41336 Posted - 1 week ago

$ADPT didn't Kathy Woods buy this stock like a month ago? It is at it's 52-wk low. Looks like a solid entry point to me.

User Image SonGoku Posted - 1 week ago

Ark adding $ADPT $CDNA $CDXS $CMIIU more

User Image TradeWithAlerts Posted - 1 week ago

Nice Print for $ADPT - Amount: $3,314,696.94 - to learn more, SIGNUP https://tradewithalerts.com/signup or get a training https://tradewithalerts.com/training!

Analyst Ratings
Morgan Stanley Equal-Weight May 7, 21
Goldman Sachs Neutral Mar 3, 21
Morgan Stanley Equal-Weight Feb 26, 21
Morgan Stanley Equal-Weight Nov 11, 20
Morgan Stanley Equal-Weight Sep 9, 20
Guggenheim Buy May 19, 20
BTIG Research Buy Jul 23, 19
Guggenheim Buy Jul 22, 19
William Blair Outperform Jul 22, 19
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own
Cohen Chad M Chief Financi.. Chief Financial Officer May 13, 7:00 PM Option 6.55 20,000 131,000 31,604
Cohen Chad M Chief Financi.. Chief Financial Officer May 13, 7:00 PM Sell 31.76 20,000 635,200 21,604
ROBINS HARLAN S Chief Scienti.. Chief Scientific Officer May 7, 9:00 PM Option 6.32 7,790 49,233 73,255
Taylor Stacy L SVP and Gener.. SVP and General Counsel May 3, 7:00 PM Option 15.35 4,166 63,948 19,202
Taylor Stacy L SVP and Gener.. SVP and General Counsel May 3, 7:00 PM Sell 41.93 4,166 174,680 15,036
ROBINS HARLAN S Chief Scienti.. Chief Scientific Officer Apr 22, 9:00 PM Option 6.32 27,265 172,315 77,150
ROBINS HARLAN S Chief Scienti.. Chief Scientific Officer Apr 22, 9:00 PM Sell 41.55 27,265 1,132,861 69,360
Palaniappan Jyoti SVP, Diagnost.. SVP, Diagnostics, T-Detect Apr 21, 6:00 PM Option 22.55 1,301 29,338 10,459
LO FRANCIS Chief People.. Chief People Officer Apr 16, 9:00 PM Option 7.8 2,000 15,600 22,604
LO FRANCIS Chief People.. Chief People Officer Apr 16, 9:00 PM Sell 43.04 2,000 86,080 20,604
BALDO LANCE Chief Medical.. Chief Medical Officer Apr 16, 9:00 PM Option 7.8 2,000 15,600 24,894
BALDO LANCE Chief Medical.. Chief Medical Officer Apr 16, 9:00 PM Sell 44.5 2,000 89,000 22,894
GRIFFIN MICHELLE RENEE Director Director Apr 16, 9:00 PM Option 7.8 4,500 35,100 6,004
GRIFFIN MICHELLE RENEE Director Director Apr 16, 9:00 PM Sell 43.41 4,500 195,345 1,504
Cohen Chad M Chief Financi.. Chief Financial Officer Apr 8, 9:00 PM Option 6.32 20,000 126,400 31,604
Cohen Chad M Chief Financi.. Chief Financial Officer Apr 8, 9:00 PM Sell 41.63 20,000 832,600 21,604
ROBINS CHAD M CEO and Chair.. CEO and Chairman Apr 8, 9:00 PM Sell 42.19 15,000 632,850 1,748,461
Taylor Stacy L SVP and Gener.. SVP and General Counsel Apr 2, 9:00 PM Option 15.35 4,167 63,963 19,203
Taylor Stacy L SVP and Gener.. SVP and General Counsel Apr 2, 9:00 PM Sell 40 4,167 166,680 15,036
ROBINS HARLAN S Chief Scienti.. Chief Scientific Officer Mar 25, 9:00 PM Option 6.32 19,475 123,082 74,650
ROBINS HARLAN S Chief Scienti.. Chief Scientific Officer Mar 25, 9:00 PM Sell 40.05 19,475 779,974 69,360
Mar 10, 7:45 PM Sell 40.63 806,000 32,747,780 12,309,090
Cohen Chad M Chief Financi.. Chief Financial Officer Mar 10, 7:00 PM Option 6.32 10,000 63,200 31,064
Cohen Chad M Chief Financi.. Chief Financial Officer Mar 10, 7:00 PM Sell 40.41 10,000 404,100 21,064
Pellini Michael J Director Director Mar 10, 7:00 PM Sell 57.8 20,000 1,156,000 1,504
Pellini Michael J Director Director Mar 10, 7:00 PM Option 6.55 20,000 131,000 21,504
HERSHBERG ROBERT Director Director Mar 10, 7:00 PM Option 0.45 2,000 900 2,000
HERSHBERG ROBERT Director Director Mar 10, 7:00 PM Sell 44.56 2,000 89,120
HERSHBERG ROBERT Director Director Mar 10, 7:00 PM Option 0.45 2,000 900 3,504
HERSHBERG ROBERT Director Director Mar 10, 7:00 PM Sell 44.56 2,000 89,120 1,504
RUBINSTEIN JULIE President President Feb 24, 9:00 PM Option 6.55 30,000 196,500 15,000
RUBINSTEIN JULIE President President Feb 24, 9:00 PM Sell 58.35 30,000 1,750,500
GRIFFIN MICHELLE RENEE Director Director Feb 16, 8:26 PM Option 7.8 6,000 46,800 7,504
GRIFFIN MICHELLE RENEE Director Director Feb 16, 8:26 PM Sell 65.08 6,000 390,480 1,504
RUBINSTEIN JULIE President President Feb 12, 8:00 PM Option 6.55 30,000 196,500 15,000
RUBINSTEIN JULIE President President Feb 12, 8:00 PM Sell 63.46 30,000 1,903,800
ROBINS CHAD M CEO and Chair.. CEO and Chairman Feb 10, 9:00 PM Sell 62.56 30,000 1,876,800 1,709,780
RUBINSTEIN JULIE President President Feb 10, 9:00 PM Option 6.4 30,000 192,000 15,000
RUBINSTEIN JULIE President President Feb 10, 9:00 PM Sell 62.31 30,000 1,869,300
RUBINSTEIN JULIE President President Feb 8, 9:00 PM Option 6.32 15,000 94,800 15,000
RUBINSTEIN JULIE President President Feb 8, 9:00 PM Sell 59.88 15,000 898,200
RUBINSTEIN JULIE President President Feb 5, 6:00 PM Option 6.32 30,000 189,600 15,000
RUBINSTEIN JULIE President President Feb 5, 6:00 PM Sell 59.68 30,000 1,790,400
ROBINS HARLAN S Chief Scienti.. Chief Scientific Officer Feb 5, 6:00 PM Option 6.32 7,790 49,233 8,469
ROBINS HARLAN S Chief Scienti.. Chief Scientific Officer Feb 5, 6:00 PM Sell 59.92 7,790 466,777 679
RUBINSTEIN JULIE President President Feb 3, 8:00 PM Option 6.32 30,000 189,600 15,000
RUBINSTEIN JULIE President President Feb 3, 8:00 PM Sell 57.83 30,000 1,734,900
Taylor Stacy L SVP and Gener.. SVP and General Counsel Feb 1, 8:00 PM Option 7.18 2,813 20,197 4,113
Taylor Stacy L SVP and Gener.. SVP and General Counsel Feb 1, 8:00 PM Sell 56.69 2,813 159,469 1,300
RUBINSTEIN JULIE President President Feb 1, 8:00 PM Option 6.32 15,000 94,800 15,000